Ionis Angioedema Drug Shows Positive Results in Phase 3 Trial (NASDAQ:IONS)
Ionis Pharmaceuticals (NASDAQ:IONS) on Monday announced positive results from the Phase 3 trial of its drug candidate donidalorsen for hereditary ...
Ionis Pharmaceuticals (NASDAQ:IONS) on Monday announced positive results from the Phase 3 trial of its drug candidate donidalorsen for hereditary ...
mikhail_petrov-96 Alpine immune sciences (NASDAQ:ALPN) said it amended its 2020 option and license agreement with AbbVie (ABBV) for acazicolcept and ...
Md Babul Hosen/iStock via Getty Images Shattuck Laboratories (NASDAQ: STTK) shares soared 90% in morning trading Wednesday after the biotech ...
SAN FRANCISCO, CA – Parent-driven PBCan educational technology company delivering research-based digital family engagement programs Ready4K, today announced the appointment ...
The quest to discover new crystal structures in materials has long been a cornerstone of scientific exploration, and has critical ...
Bet_Noire/iStock via Getty Images MorphoSys(NASDAQ:MOR) said a Phase 3 study for its drug pelabresib met its primary endpoint in treating ...
Understanding phase change materials and creating cutting-edge memory technologies can greatly benefit from the use of computer simulations. However, direct ...
bitcoin (btc) is on track to hit $45,000 in November as part of a classic btc price cycle, popular analyst ...
You may not realize it yet, but the price of bitcoin could be in a bull market, on the cusp ...
An educational center could open on the site of the famous Arecibo Observatory in Puerto Rico early next year, but ...